Acetyl-Histone H2A.X (Lys5) Antibody

What is Acetyl-Histone H2A.X (Lys5) and why is it significant in epigenetic research?

Acetyl-Histone H2A.X (Lys5) refers to the acetylation of the histone variant H2A.X at lysine 5. This post-translational modification plays a crucial role in chromatin remodeling and DNA damage response (DDR) signaling. The acetylation of H2A.X at Lys5 is particularly significant because it facilitates H2A.X exchange at sites of DNA damage, which is essential for proper DNA repair processes . Unlike phosphorylation of H2A.X at Ser139 (γ-H2A.X), which is more widely studied, the acetylation at Lys5 represents a distinct regulatory mechanism in chromatin dynamics during DNA damage response .

What are the standard applications for Acetyl-Histone H2A.X (Lys5) antibodies?

Acetyl-Histone H2A.X (Lys5) antibodies are utilized in multiple experimental approaches:

These applications enable researchers to investigate the presence, abundance, and genomic distribution of this specific histone modification in various experimental contexts .

How does the specificity of Acetyl-Histone H2A.X (Lys5) antibody compare to other histone acetylation antibodies?

The specificity of Acetyl-Histone H2A.X (Lys5) antibody is determined by its ability to recognize the unique epitope around acetylated lysine 5 on the H2A.X variant. This antibody does not cross-react with acetylation marks at other lysine residues on H2A.X or with acetylated lysines on other histone variants . This specificity contrasts with antibodies targeting other acetylation sites, such as those for acetylated H4K5, which recognize a different pattern of acetylation associated with different biological functions . Validation experiments typically demonstrate that the antibody specifically recognizes the acetylated form and not the unmodified peptide in dot blot analyses or when comparing TSA-treated (hyperacetylated) versus untreated cell extracts .

What are the optimal sample preparation methods for detecting Acetyl-Histone H2A.X (Lys5) in different experimental contexts?

For optimal detection of Acetyl-Histone H2A.X (Lys5) across different experimental approaches:

Western Blotting:

• Extract histones using acid extraction methods to enrich for histones

• Include histone deacetylase inhibitors (e.g., sodium butyrate, TSA) in lysis buffers to preserve acetylation marks

• Use SDS-PAGE with 15-18% acrylamide gels to properly resolve the low molecular weight (14 kDa) histone proteins

Chromatin Immunoprecipitation:

• Optimize crosslinking time (typically 10-15 minutes with 1% formaldehyde)

• Ensure thorough sonication to generate 200-500 bp DNA fragments

• Include protease inhibitors and histone deacetylase inhibitors in all buffers

Immunohistochemistry:

• Heat-mediated antigen retrieval in citrate buffer (pH 6.0)

• Block with 5% BSA or serum to reduce background

• Use signal amplification methods for enhanced detection

Proper sample preparation is critical as acetylation marks can be lost through enzymatic deacetylation during sample handling if appropriate inhibitors are not included .

How should researchers validate the specificity of Acetyl-Histone H2A.X (Lys5) antibody signals in their experiments?

Comprehensive validation of antibody specificity should include:

• Positive controls: Treat cells with histone deacetylase inhibitors (e.g., TSA, sodium butyrate) to increase global acetylation levels and confirm signal enhancement

• Negative controls:

  • Use H2A.X knockout cells or depleted samples as negative controls

  • Perform peptide competition assays using acetylated and non-acetylated peptides

• Orthogonal validation:

  • Confirm findings using multiple antibodies from different sources

  • Validate with alternative techniques like mass spectrometry

  • Use mutant histones (K5R substitution) that cannot be acetylated at this position

• Cross-reactivity assessment:

  • Test against other acetylated histone peptides to confirm no cross-reactivity

  • Particularly important to distinguish from other H2A variants with similar sequences

This multi-faceted approach ensures that the detected signals genuinely represent Acetyl-Histone H2A.X (Lys5) and not other modified histones or non-specific binding .

How does TIP60 histone acetyltransferase regulate the acetylation of H2A.X at Lys5 during DNA damage response?

The TIP60 histone acetyltransferase complex specifically targets H2A.X for acetylation at Lys5 during DNA damage response through the following mechanism:

• Upon DNA damage, the TIP60 complex is recruited to damaged chromatin regions where phosphorylated H2A.X (γ-H2A.X) is present

• TIP60 catalyzes the acetylation of H2A.X at Lys5, which occurs independently of H2A.X phosphorylation at Ser139 (γ-H2A.X)

• This acetylation facilitates H2A.X exchange at damage sites, promoting chromatin remodeling necessary for repair factor access

• Importantly, the acetylation of H2A.X at Lys5 by TIP60 is essential for the turnover of NBS1 (a component of the MRN complex) on damaged chromatin

• The absence of H2A.X acetylation at Lys5 by TIP60 in cells disturbs the accumulation of NBS1 at DNA damage sites, affecting downstream repair pathways

Research has shown that cells expressing TIP60 HAT mutant (TIPM), which lacks histone acetyltransferase activity, still form γ-H2A.X and MDC1 foci after DNA damage, confirming that phosphorylation and acetylation of H2A.X occur independently during DDR signaling .

What is the relationship between Acetyl-Histone H2A.X (Lys5) and the regulation of NBS1 dynamics during DNA damage repair?

The relationship between Acetyl-Histone H2A.X (Lys5) and NBS1 dynamics during DNA damage repair is complex and mechanistically significant:

• While H2A.X phosphorylation (γ-H2A.X) is required for the initial recruitment and retention of NBS1 at DNA damage sites, H2A.X acetylation at Lys5 by TIP60 is specifically required for proper NBS1 turnover on damaged chromatin

• Studies have demonstrated that acetylation of H2A.X at Lys5 is essential for the accumulation of NBS1 at damage sites, but not for its initial recruitment

• In H2A.X-deleted zygotes, the resumption of cell cycle progression after irradiation occurs significantly earlier than in wild-type zygotes, indicating that the maintenance of irradiation-induced cell cycle arrest is impaired in the absence of H2A.X

• Acetylation-dependent NBS1 turnover by TIP60 on damaged chromatin restricts the dispersal of NBS1 foci from the sites of DNA damage, ensuring localized repair activity

• This acetylation-dependent regulation is distinct from phosphorylation-dependent mechanisms, highlighting the multi-layered control of DNA damage response proteins

This relationship reveals how distinct histone modifications coordinate to regulate the spatiotemporal dynamics of repair factors at DNA damage sites .

How does H2A.X acetylation at Lys5 differ functionally from other post-translational modifications of H2A.X?

H2A.X acetylation at Lys5 serves distinct functional roles compared to other post-translational modifications of H2A.X:

Key functional differences:

• Temporal dynamics: While phosphorylation of H2A.X at Ser139 occurs rapidly after DNA damage and serves as an initial signal, acetylation at Lys5 regulates subsequent chromatin dynamics and repair factor turnover

• Mechanistic role: Acetylation at Lys5 specifically facilitates H2A.X exchange at damage sites, whereas phosphorylation primarily serves as a docking site for repair factors

• Independence of regulation: Research has shown that phosphorylation and acetylation of H2A.X occur independently of each other upon DNA damage response, demonstrating parallel regulatory pathways

• Developmental significance: H2A.X, but not the TH2A variant, is involved in the DNA damage response of zygotes, highlighting the specificity of H2A.X modifications in developmental contexts

These distinct functions illustrate how different post-translational modifications on H2A.X coordinate to orchestrate the complex DNA damage response process .

What are common challenges in detecting Acetyl-Histone H2A.X (Lys5) and how can researchers address them?

Researchers commonly encounter several challenges when detecting Acetyl-Histone H2A.X (Lys5):

• Low signal intensity:

  • Increase antibody concentration (e.g., try 1:500 instead of 1:1000 for Western blotting)

  • Use signal amplification systems (HRP-polymer or TSA-based methods)

  • Pre-treat samples with HDAC inhibitors to preserve acetylation marks

• High background signals:

  • Increase blocking time and concentration (5% BSA or milk)

  • Optimize antibody dilution through titration experiments

  • Include additional washing steps with higher salt concentration

• Cross-reactivity issues:

  • Perform peptide competition assays to verify specificity

  • Use H2A.X knockout cells as negative controls

  • Consider alternative antibodies from different suppliers

• Sample preparation problems:

  • Add HDAC inhibitors to all buffers (sodium butyrate 5-10 mM)

  • Keep samples cold throughout processing

  • Minimize time between sample collection and fixation/extraction

• Inconsistent ChIP results:

  • Optimize chromatin sonication to generate 200-500 bp fragments

  • Increase crosslinking time for stronger protein-DNA interactions

  • Verify antibody efficacy in IP before performing ChIP

Addressing these challenges requires systematic optimization of each experimental parameter while maintaining careful controls .

How should researchers interpret contradictory results between detection methods for Acetyl-Histone H2A.X (Lys5)?

When confronted with contradictory results between different detection methods for Acetyl-Histone H2A.X (Lys5), researchers should:

• Consider method-specific limitations:

  • Western blotting provides bulk analysis but may miss cell-specific variations

  • Immunofluorescence reveals spatial distribution but may lack quantitative precision

  • ChIP assesses genomic localization but can be affected by crosslinking efficiency

• Evaluate antibody performance across applications:

  • Some antibodies perform better in certain applications than others

  • Verify antibody validation data for each specific application

  • Consider using multiple antibodies targeting the same modification

• Analyze experimental conditions systematically:

  • Compare fixation/extraction methods between techniques

  • Assess buffer compositions for compatibility with the modification

  • Consider the timing of sample collection relative to biological events

• Implement orthogonal validation:

  • Confirm findings with mass spectrometry-based approaches

  • Use genetic approaches (K5R mutations) to validate antibody specificity

  • Apply pharmacological treatments (HDAC inhibitors, TIP60 inhibitors) to manipulate acetylation levels

• Context-dependent modification levels:

  • Acetylation levels may vary dramatically based on cell cycle phase

  • DNA damage induction may create heterogeneous cell populations

  • Consider single-cell approaches to resolve population heterogeneity

Resolving such contradictions often leads to deeper mechanistic insights about the biology of the modification and the technical limitations of detection methods .

How does acetylation at H2A.X Lys5 compare functionally to similar modifications on other histone variants?

Acetylation of H2A.X at Lys5 shares similarities with acetylation at analogous positions on other histone variants, but with distinct functional outcomes:

Key comparative insights:

• While acetylation occurs at similar lysine positions across histone variants, the functional consequences are specialized based on the variant's primary role

• H2A.X Lys5 acetylation specifically functions in DNA damage response pathways, whereas similar modifications on canonical H2A or H2B primarily affect transcriptional regulation

• H2A.Z shows a pattern of multiple acetylations (Lys 5, 7, 11) that function cooperatively, distinguishing it from the single-site modification on H2A.X

• The TIP60 complex acetylates both H2A.X at Lys5 and H4 at Lys5, suggesting coordinated regulation of these modifications in certain contexts

• The specialized role of H2A.X Lys5 acetylation in DNA damage reflects the broader specialization of H2A.X in genome integrity pathways compared to other variants

This comparative analysis highlights how similar chemical modifications acquire distinct biological functions based on the histone variant context .

What are the latest methodological advances for studying the dynamics of H2A.X Lys5 acetylation in living cells?

Recent methodological advances for studying H2A.X Lys5 acetylation dynamics in living cells have expanded our understanding of this modification:

• Live-cell imaging approaches:

  • Engineered acetylation-specific intrabodies fused to fluorescent proteins

  • FRET-based sensors for detecting acetylation state changes in real time

  • Correlative light and electron microscopy to link acetylation signals to ultrastructural features

• Improved ChIP-seq methodologies:

  • CUT&RUN and CUT&Tag offer improved signal-to-noise ratio compared to traditional ChIP

  • Single-cell ChIP-seq reveals cell-to-cell variability in acetylation patterns

  • ChIC/CUT&RUN Service provides high-resolution mapping of acetylation sites

• Mass spectrometry innovations:

  • Targeted MS approaches using parallel reaction monitoring for quantitative analysis

  • Modified Spec® Service for comprehensive histone PTM profiling

  • Cross-linking mass spectrometry to identify proteins interacting with acetylated H2A.X

• Genetic engineering tools:

  • CRISPR-Cas9 knock-in of specifically modifiable H2A.X variants

  • Optogenetic control of TIP60 acetyltransferase activity

  • Acetylation-mimetic mutations (K5Q) and acetylation-deficient mutations (K5R) for functional studies

• Proteomics approaches:

  • Proximity labeling (BioID, APEX) to identify proteins associated with acetylated H2A.X

  • RIME (Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins) for interactome analysis

  • Fractionation methods to isolate distinct chromatin compartments with differential acetylation

These methodological advances enable researchers to move beyond static snapshots to dynamic understanding of acetylation processes in living cells, providing unprecedented insights into the temporal and spatial regulation of H2A.X Lys5 acetylation .

What are the emerging questions about the role of Acetyl-Histone H2A.X (Lys5) in developmental processes and disease pathogenesis?

Several emerging questions are shaping future research on Acetyl-Histone H2A.X (Lys5) in development and disease:

• Developmental regulation:

  • How does H2A.X Lys5 acetylation regulate zygotic genome activation and early embryonic development?

  • Does this modification play differential roles across tissue-specific stem cell populations?

  • What is the relationship between H2A.X Lys5 acetylation and developmental DNA damage checkpoints?

• Cancer biology implications:

  • How is H2A.X Lys5 acetylation altered in cancer cells with dysregulated DNA repair?

  • Could targeting TIP60-mediated H2A.X acetylation sensitize resistant tumors to genotoxic therapies?

  • Does aberrant H2A.X Lys5 acetylation contribute to genomic instability in specific cancer types?

• Neurological disease connections:

  • What role does H2A.X Lys5 acetylation play in neurodegenerative diseases associated with DNA damage?

  • How does this modification influence neuronal response to oxidative stress?

  • Is there a link between H2A.X acetylation patterns and age-related cognitive decline?

• Therapeutic targeting potential:

  • Can small molecule modulators of H2A.X Lys5 acetylation be developed as therapeutic agents?

  • Would inhibition of TIP60-mediated acetylation enhance DNA damage-inducing cancer therapies?

  • How might manipulation of this modification affect cellular reprogramming efficiency?

• Aging and stress response:

  • How does H2A.X Lys5 acetylation change during cellular aging?

  • Is this modification involved in organismal stress adaptation mechanisms?

  • Could H2A.X acetylation patterns serve as biomarkers for biological aging?

These questions represent important frontiers in understanding the broader biological significance of this specific histone modification beyond its established role in DNA damage response .

How can integrative omics approaches enhance our understanding of the biological significance of H2A.X Lys5 acetylation?

Integrative omics approaches offer powerful strategies to comprehensively understand H2A.X Lys5 acetylation's biological significance:

• Multi-omics integration frameworks:

  • Combining ChIP-seq of Acetyl-H2A.X (Lys5) with RNA-seq to correlate acetylation patterns with transcriptional outputs

  • Integrating acetylome, phosphoproteome, and ubiquitylome data to map PTM crosstalk networks

  • Correlating epigenomic datasets with metabolomic profiles to identify metabolic regulators of acetylation

• Temporal and spatial mapping approaches:

  • Time-course experiments capturing dynamic changes in acetylation following DNA damage

  • Cell-type-specific profiling across developmental stages or disease progression

  • Subcellular fractionation approaches to distinguish chromatin compartment-specific acetylation patterns

• Network biology applications:

  • Constructing protein-protein interaction networks centered on acetylated H2A.X

  • Pathway enrichment analyses to identify cellular processes influenced by this modification

  • Machine learning approaches to predict functional consequences of acetylation patterns

• Single-cell multi-omics:

  • Single-cell chromatin accessibility (scATAC-seq) combined with acetylation profiling

  • Spatial transcriptomics correlated with immunofluorescence detection of acetylation

  • Trajectory inference analyses to map acetylation dynamics during cellular transitions

• Computational modeling approaches:

  • Molecular dynamics simulations of how acetylation affects nucleosome structure

  • Mathematical modeling of DNA damage response kinetics incorporating acetylation dynamics

  • Systems biology models predicting cellular phenotypes based on histone modification patterns